Clinical Trial Update: RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial of RTA 744 in breast cancer patients with progression of previously irradiated brain metastases has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• RTA 744

Snippet

Sponsor: Biogen | Conditions: Brain Metastases | Phase 2 | Status: TERMINATED